These results suggest that adenocarcinoma may include more EDIL3-positive cells and respond more robustly to EDIL3 than squamous cell carcinoma, resulting in tumor angiogenesis, presence of a mesenchymal phenotype, and poor clinical outcome. The gene discussed is EDIL3; the disease is adenocarcinoma.